New acridone-4-carboxylic acid derivatives as potential inhibitors of Hepatitis C virus infection
A series of N-substituted acridone-4-carboxamides have been synthesized and their anti-HCV and anti-T7 polymerase activity tested. Two compounds were efficient inhibitors of HCV RNA replication in a human hepatoma cell line. A new class of compounds—acridone derivatives—was tested using the direct f...
Saved in:
Published in: | Bioorganic & medicinal chemistry Vol. 16; no. 19; pp. 8846 - 8852 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Amsterdam
Elsevier Ltd
01-10-2008
Elsevier |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | A series of
N-substituted acridone-4-carboxamides have been synthesized and their anti-HCV and anti-T7 polymerase activity tested. Two compounds were efficient inhibitors of HCV RNA replication in a human hepatoma cell line.
A new class of compounds—acridone derivatives—was tested using the direct fluorometric helicase activity assay to determine the inhibitory properties of the derivatives towards the NS3 helicase of
Hepatitis C virus (HCV). The compounds were also tested as putative transcription inhibitors of in vitro transcription based on the DNA-dependent T7 RNA polymerase. Most of the acridone derivatives tested were transcription inhibitors; however, only four of them inhibited the NS3 helicase at low concentrations (IC
50 from 3
μM to 20
μM) and were therefore selected for further studies on the mechanism of inhibition. The acridone derivatives probably act via intercalation into double-stranded nucleic acids but they may also interact directly with viral enzymes. Selected carboxamides were tested in the subgenomic HCV replicon system. Two of the compounds:
N-(pyridin-4-yl)-amide and
N-(pyridin-2-yl)-amide of acridone-4-carboxylic acid are efficient RNA replication inhibitors with selectivity indexes of 19.4 and 40.5, respectively, proving that the acridone derivatives may be regarded as potential antiviral agents. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2008.08.074 |